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ABSTRACT Currently inherited or acquired skeletal
muscle mitochondrial dysfunction is linked to dysregu-
lated fatty acid metabolism, resulting in increased
levels of intramyocellular lipids (IMCLs) and lipid
intermediates, inducing insulin resistance. The present
study aimed to clarify the order of changes in IMCL
levels and skeletal muscle mitochondrial function dur-
ing the development of type 2 diabetes in Zucker
diabetic fatty (ZDF) rats. IMCL levels and skeletal
muscle oxidative capacity were determined in vivo,
using localized 1H magnetic resonance spectroscopy
(MRS) and dynamic 31P MRS, respectively. In parallel,
in vitro activities were measured from enzymes involved
in fatty acid oxidation, the tricarboxylic acid cycle and
the electron transport chain. Fa/fa ZDF rats were
studied at 3 different ages corresponding to different
stages of type 2 diabetes, whereas fa/ rats served as
controls. Fa/fa ZDF rats had higher IMCL contents
than controls throughout the duration of the study. In
vivo muscle oxidative capacity was not different in
fa/fa animals compared to controls, and in vitro en-
zyme activity data suggested improved functionality of
enzymes involved in fat oxidation in type 2 diabetic
animals. Accordingly, we can conclude that in the ZDF
rat model, type 2 diabetes develops in the absence of
skeletal muscle mitochondrial dysfunction.—De Feyter,
H. M., Lenaers, E., Houten, S. M., Schrauwen, P.,
Hesselink, M. K., Wanders, R. J. A., Nicolay, K., Promp-
ers, J. J. Increased intramyocellular lipid content but
normal skeletal muscle mitochondrial oxidative capac-
ity throughout the pathogenesis of type 2 diabetes.
FASEB J. 22, 3947–3955 (2008)
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Skeletal muscle accounts for the great majority of
insulin-stimulated glucose uptake (1), and insulin resis-
tance of skeletal muscle tissue is one of the earliest
detectable disturbances in the development of type 2
diabetes [reviewed by Petersen and Shulman (2)]. It
has been shown that insulin sensitivity is negatively
correlated with the amount of intramyocellular lipids
(IMCLs) stored inside skeletal muscle cells. This rela-
tionship has been described in sedentary humans (3–6)
as well as in rat models of insulin resistance and type 2
diabetes (7–9). A causal relationship between IMCL
accumulation and insulin resistance has never been
demonstrated, but there are strong indications that
intermediates of lipid metabolism, such as long-chain
acyl-CoAs, diacylglycerol, and/or ceramides impede
the insulin signaling rather than the stored triglycerides
themselves (10, 11).
Recently, insulin resistance has also been associated
with skeletal muscle mitochondrial dysfunction (12,
13). Data originating from in vivo magnetic resonance
spectroscopy (MRS) measurements (14–17), in vitro
enzyme activity assays (18–21), and expression analysis
of genes involved in oxidative metabolism (22, 23)
suggest that skeletal muscle mitochondrial dysfunction
plays a role in insulin resistance and type 2 diabetes.
Current hypotheses link inherited or acquired mito-
chondrial dysfunction to impaired fatty acid metabo-
lism, which subsequently results in increased levels of
IMCLs and lipid intermediates, inducing insulin resis-
tance (2, 13–15, 24).
Studies in humans investigating the relations among
mitochondrial function, IMCLs, and insulin resistance
or type 2 diabetes have been carried out using cross-
sectional study designs. Because these studies only provide
correlative information, it is impossible to unravel cause
and consequence. In an attempt to bypass these limita-
tions, we studied an established animal model of type 2
diabetes, the Zucker diabetic fatty (ZDF) rat, aiming to
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clarify the order in which changes in IMCLs and in vivo
skeletal muscle mitochondrial function occur during
the development of type 2 diabetes. Localized 1H MRS
was used to determine IMCL content, and dynamic 31P
MRS was applied in combination with a minimally
invasive electrical stimulation method to measure post-
exercise resynthesis kinetics of phosphocreatine (PCr).
The postexercise PCr recovery time constant provides a
measure of in vivo muscle oxidative capacity because
the muscle contractions create a highly activated state
of the mitochondria (i.e., high ADP levels) and ATP
used to restore the PCr pool during recovery is origi-
nating exclusively from mitochondrial oxidative phos-
phorylation (25).
Fa/fa ZDF rats were studied in vivo in a longitudinal
study design at ages corresponding to 1) a normogly-
cemic-hyperinsulinemic state (prediabetic), 2) a hyper-
glycemic-hyperinsulinemic state (overt type 2 diabetes),
and 3) a late type 2 diabetes stage characterized by
hyperglycemia and progressive -cell failure (26). Het-
erozygous fa/ rats remain normoglycemic and nor-
moinsulinemic and served as controls (26). In addition,
muscle tissue was collected from parallel groups of
animals at the same time points as the in vivo MRS
measurements to measure in vitro activities of enzymes/
complexes of -oxidation, tricarboxylic acid (TCA)
-cycle, and electron transport chain (ETC) in homoge-
nized muscle samples.
Based on phenotypical characteristics of fa/fa rats,
we hypothesized that the development of overt type 2
diabetes in fa/fa rats would be paralleled by a progres-
sive loss of in vivo mitochondrial oxidative capacity and
increase in IMCL content compared to the control
fa/ rats. Similarly, in vitro enzyme activities were
expected to progressively decrease in fa/fa rats with
advancing type 2 diabetes.
MATERIALS AND METHODS
Animals
Male obese ZDF rats (ZDF/Gmi, fa/fa; n22) and lean
littermates (ZDF/Gmi, fa/; n23) (Charles River Labora-
tories, The Netherlands) were housed in pairs at 20°C and
50% humidity, on a 12-h light-dark cycle with ad libitum access
to water and chow during the entire study. Animals arrived at
the laboratory at 5 wk of age. From 7 wk of age, animals
received a diet containing, as percentage of calories, 16.7%
fat, 56.4% carbohydrates and 26.8% protein (Altromin, Lage,
Germany). Body weight and food intake were monitored
weekly. Principles of laboratory animal care were followed
and all experimental procedures were approved by the Ani-
mal Ethics Committee of Maastricht University.
MRS groups
In 10 fa/fa and 11 fa/ animals, IMCL levels and skeletal
muscle oxidative capacity were measured in tibialis anterior
(TA) muscle by applying in vivo 1H and 31P MRS, respectively,
at 6, 12, and 18 wk of age. In the week after the last MRS
experiments (19 wk of age), the animals were killed and
muscle tissue was harvested according to procedures de-
scribed for the parallel groups.
Parallel groups
Parallel to the MRS measurements, ZDF rats were killed at 6
(fa/fa, n6; fa/, n6) and 12 (fa/fa, n6; fa/, n6) wk
of age by cervical dislocation within 20 s following CO2
sedation. TA muscles were excised, and midbelly portions
were rapidly frozen in liquid nitrogen and stored at 80°C.
MRS
All MRS measurements were performed on a 6.3 T horizontal
Bruker MR system (Bruker, Ettlingen, Germany). During
preparatory surgical procedures and MRS experiments, ani-
mals were anesthetized using 1–2% isoflurane (Forene; Abbot
GmbH, Wiesbaden, Germany) administered via a face mask
with medical air (0.4 L/min), and body temperature was
maintained at 37  1°C using heating pads. In the MR
scanner, respiration was monitored using a pressure sensor
registering thorax movement (Rapid Biomedical, Rimpar,
Germany).
Single-voxel localized 1H MRS was applied to measure
IMCL levels in TA, as described elsewhere (27) except that no
additional outer volume suppression was used. In short, 2
voxels of 2  2  2 mm3 were subsequently measured in white
(ventral) and red (dorsal) TA, respectively, using an ellipsoid
1H surface coil (18/22 mm). The 1H MR spectra were
acquired using the LASER (localization by adiabatic selective
refocusing) sequence (28) [repetition time TR1 s, echo time
TE16 ms, SWAMP (sequence for water suppression with
adiabatic modulated pulses) water suppression (29), 512 aver-
ages].
31P MRS was applied using a combination of a circular 1H
surface coil (40 mm) and an ellipsoid 31P surface coil (10/18
mm) positioned over the TA. Localized shimming was per-
formed on the water signal using the 1H surface coil. 31P
spectra were acquired applying an adiabatic excitation pulse
with a flip angle of 90°. A fully relaxed spectrum (TR20 s, 32
averages) and a partially saturated spectrum (TR5 s, 128
averages) were measured at rest, followed by the acquisition
of a time series of spectra (TR5 s, 4 averages) before,
during, and after electrical stimulation of TA. Electrical
stimulation was applied via acute, subcutaneously implanted
platinum electrodes positioned along the distal nerve trajec-
tory of the n. peroneus communis to induce contractions in
the TA. A time series consisted of 3 min rest, 2 min of
electrical stimulation, and 10 min of recovery. Stimulation
pulse length was 100 ms, frequency was 80 Hz, stimulation
voltage varied between 2 and 4 V, and pulses were applied
1/s. For each rat, at each age at least 3 consecutive time series
were performed. During the first time series, stimulation
voltage was adjusted to assure significant depletion of PCr in
subsequent time series. The latter 2 time series were used for
analysis of PCr recovery kinetics.
Both 31P and 1H MR spectra were fit in the time domain by
using a nonlinear least squares algorithm in the jMRUI
software package (30). 1H MR spectra were fit as described
elsewhere (27). IMCL was then expressed relative to total
creatine (tCr). For the 31P MR spectra recorded at rest, PCr
and the intra- and extracellular inorganic phosphate (Pi)
peaks (31) were fit to Lorentzian line shapes. The - and
-ATP peaks were fit to Gaussian line shapes with equal peak
areas. Due to limited bandwidth of the excitation pulse, the
-ATP had lower amplitude and was not fit. In 31P MR spectra
from the time series, peaks from intra- and extracellular Pi
could not be distinguished; therefore, a single Pi peak was fit
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to a Gaussian line shape. Absolute concentrations of the
phosphorylated metabolites were calculated after correction
for partial saturation with the assumption that the ATP
concentration is 8.2 mM at rest (32). Intracellular pH was
calculated from the chemical shift difference between the Pi
and PCr resonances (33). The free cytosolic ADP concentra-
tion was calculated from the PCr concentration and pH using
a creatine kinase equilibrium constant (Keq) of 1.66  10
9
M–1 (34) and the assumption that 15% of the total creatine is
unphosphorylated at rest (35). For the time series, the PCr
line width during recovery was constrained to the average PCr
line width during recovery (excluding the first 5 data points)
obtained from a prior, unconstrained fit. The data of PCr
resynthesis were fit to a monoexponential function using
Matlab (version 6.5, Mathworks, Natick, MA, USA) yielding a
time constant 	PCr, which is a measure of skeletal muscle
mitochondrial oxidative capacity. Two time series with similar
end-exercise pH values were analyzed for each animal, result-
ing in 2 values of 	PCr, which were averaged.
In vitro enzyme activities
Muscle tissue (frozen microtome section) was disrupted using
sonication (twice at 8-W output, 40 J, on ice) in homogeniza-
tion buffer (50 mM Tris, 120 mM NaCl, 5mM KCl, 1 mM
MgSO4, 1 mM CaCl2, and 10% glycerol, pH 7.4). The
homogenates were centrifuged for 5 min at 1000 g. Protein
concentration was determined in the supernatant using the
Bradford method. The homogenates were diluted to 
1
mg/mL. Very long chain acyl-CoA dehydrogenase (VLCAD)
activity was measured as described elsewhere, using palmitoyl-
CoA as substrate (36). The production of trans-2,3-palmitoyl-
CoA and l-3-hydroxypalmitoyl-CoA was quantified by HPLC
and used to calculate acyl-CoA dehydrogenase activity. Citrate
synthase (CS) was measured spectrophotometrically at 412
nm by the formation of free CoA using 5,5-dithio-bis-(2-
nitrobenzoic acid) (37). Succinate dehydrogenase (SDH) was
measured using a method described by Munujos et al. (38).
Cytochrome c oxidase (complex IV) activity was measured by
following the formation of oxidized cytochrome c at 550 nm
using a method described by Cooperstein and Lazarow (39).
Plasma parameters
Blood samples were collected from animals via the retro-
orbital plexus at 6, 12, and 18 wk of age, under isoflurane
anesthesia, after 4 h of food deprivation (randomly n6/
genotype). The blood samples were collected in K-EDTA
coated tubes and centrifuged for 10 min at 1000 g, and
plasma aliquots were frozen in liquid nitrogen and stored at
80°C. Plasma glucose content was determined using the
hexokinase method (Roche, Basel, Switzerland), and free
fatty acids (FFAs) were measured with the Wako NEFA C test
kit (Wako Chemicals, Neuss, Germany). Fasting plasma insu-
lin concentrations were determined using an ultrasensitive
solid phase two-site ELISA kit (Mercodia, Uppsala, Sweden).
Statistical analysis
Data are presented as means  sd. MRS data were analyzed
using ANOVA for repeated measures with 1 within-subjects
factor (age) and 1 between-subjects factor (genotype). Bon-
ferroni corrected post hoc tests were carried out in order to
identify differences between different ages. Two-way ANOVA
was used to analyze the metabolic plasma parameters and the
in vitro enzyme activities. When there was a significant effect
of the interaction term age  genotype, data were analyzed
again using the relevant ANOVA for each genotype separately
to detect effects of age. Independent sample t tests were used
at different ages to detect differences between genotypes. All
tests were performed two-sided using SPSS 14.0 (SPSS Inc,




Body weight was higher in fa/fa than in fa/ rats
during the entire study (P0.001 at every time point).
Fa/fa rats had a higher body weight at the start of the
study and appeared to increase in body weight at a
higher rate than fa/ animals between week 6 and 11.
Ad libitum food intake of fa/fa rats was higher than that
of fa/ rats over the entire study duration (P0.001 at
every time point).
Plasma concentrations of glucose, insulin, and FFAs
determined at 6, 12, and 18 wk of age are depicted in
Fig. 1. For both glucose and insulin, there was a
significant age  genotype interaction (P0.001 and
P0.04, respectively), which was attributable to the
age-related changes in fa/fa rats. Fa/ animals dis-
played normal and constant glucose and insulin levels
throughout the entire study (Fig. 1a, b). At all ages, the
glucose and insulin levels were significantly higher in
Figure 1. Fasting plasma concentrations of glucose (a), insulin (b), and FFA (c) at 6, 12, and 18 wk of age. Filled bars, fa/fa rats;
open bars, fa/ rats. *P  0.05 vs. fa/ rats of the same age; $P  0.05 vs. 6- and 18-wk-old fa/fa rats. Error bars represent sd.
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fa/fa rats compared to controls (P0.001 for glucose
and P0.05 for insulin). The plasma data confirm that
at 6 wk of age, fa/fa animals were euglycemic-hyperin-
sulinemic (prediabetic); at 12 wk, fa/fa animals were
diabetic, displaying hyperglycemia and hyperinsulin-
emia; and at 18 wk, they were in an advanced diabetic
state, with hyperglycemia but decreased insulin levels
compared to 12 wk. Both genotypes showed similar and
constant plasma FFA levels during the period of the
study (Fig. 1c).
IMCLs
Figure 2a, b shows representative examples of 1H MR
spectra measured in red TA of a fa/fa and a fa/ rat,
respectively, at the age of 12 wk. The spectra clearly
depict the increased amplitude of the IMCL resonances
measured in the fa/fa rat compared to the control
fa/ rat. The mean IMCL levels at different ages for
white and red regions of the TA muscle are presented
in Fig. 2c, d, respectively. In both genotypes and at all
ages, IMCL levels were 
2–3 times higher in the red
region of the TA compared to the white region. There
was a significant age  genotype interaction effect for
IMCLs in both red and white regions of the TA muscle.
Analyzing the age effect on IMCL levels within each
genotype separately showed a trend toward a decrease
(P0.077) in white TA and a significant decrease in red
TA (P0.01) of fa/ animals. In contrast, IMCL levels
significantly increased in fa/fa rats between 6 and 12 wk
of age (red and white TA, both P0.01), and decreased
again between 12 and 18 wk of age in white TA
(P0.012), and tended to decrease in red TA
(P0.09). IMCL levels were significantly higher in
fa/fa rats compared to fa/ animals for both the
white and red region of the TA at all ages (all
P0.05). Compared to the euglycemic-hyperinsuline-
mic state (6 wk of age), the difference in IMCL
content was amplified in the hyperglycemic-hyperin-
sulinemic state (12 wk of age), and IMCL levels
remained much higher in fa/fa rats compared to
fa/ animals in the advanced diabetic state.
31P MRS
Table 1 lists the 31P metabolite concentrations and pH
at rest. The intracellular Pi concentration [Pi] and
[Pi]/[PCr] was higher in fa/fa rats than in fa/ rats
(both P0.001) at all time points. Both parameters
were changing during maturation in both genotypes:
[Pi] increased between 12 and 18 wk of age (P0.001),
and [Pi]/[PCr] decreased between 6 and 12 wk of age
(P0.023), but increased again between 12 and 18 wk
of age (P0.001). There was also an effect of aging in
both genotypes on [PCr], [ADP], and pH, which all
increased from 6 to 12 wk of age ([PCr] and [ADP]:
P0.001; pH: P0.001), but remained constant during
further maturation.
Figure 3a shows a stack plot of spectra measured
during a rest-exercise-recovery protocol and demon-
strates how the PCr signal drops when the electrical
stimulation starts, reaches a steady state, and then
recovers when ceasing stimulation. End-exercise metab-
olite concentrations and pH are presented in Table 2.
Figure 2. Examples of water-suppressed 1H MR
spectra measured in red TA from a 12-wk-old
fa/fa (a) and fa/ (b) rat. Peak annotations:
H2O, residual water; EMCL, extramyocellular
lipids. IMCL content at different ages in white
(c) and red TA (d). Filled bars, fa/fa rats; open
bars, fa/ rats. *P  0.05 vs. fa/fa rats of the
same age; $P  0.05 vs. 6-wk-old rats of same
genotype; #P  0.05 vs. 12-wk-old fa/fa rats.
Error bars represent sd.
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End-exercise [Pi] was higher in fa/fa than in fa/
animals. The other metabolite’s concentrations were
similar in both genotypes. End-exercise [PCr], [ADP],
and pH were higher at 12 wk compared to 6 wk of age,
which can most probably be attributed to the applied
electrical stimulation protocol. At 12 wk of age, (erro-
neously) slightly less strenuous contractions were in-
duced, explaining the differences in end-exercise [PCr],
[ADP], and pH. At each age, however, end-exercise pH
did not differ between genotypes.
Figure 3b depicts an example of the PCr recovery fit.
The mean R2 for the fit procedure of the individual
recovery datasets was 0.96  0.03. The mean PCr recovery
time constants of both genotypes at different ages are
depicted in Fig. 3c. Repeated-measures ANOVA revealed
no significant effect of genotype or genotype  age on
	PCr. However, in both genotypes, there was a significant
effect of age; that is, at 12 wk 	PCr was greater than at 6 wk,
and at 18 wk 	PCr was greater than at 12 wk (all P0.001),
indicating a significant decrease in muscle in vivo oxida-
tive capacity with aging.
In vitro enzyme assays
We measured activities of VLCAD (Fig. 4a), CS (Fig. 4b),
SDH (Fig. 4c), and complex IV (Fig. 4d) in the different
ZDF genotypes at different ages in order to evaluate
mitochondrial function in vitro. The statistical analysis of
VLCAD activities revealed a borderline significance
(P0.06) for the interaction of age and genotype and a
significant effect of genotype (P0.001): higher VLCAD
activities were measured in fa/fa animals compared to
fa/ rats at 12 and 19 wk of age (Fig. 4a). CS activities
displayed a significant genotype effect (P0.045) in the
ANOVA, which became weaker in the post hoc compari-
sons: at 19 wk of age, fa/fa rats showed a trend for higher
CS activity compared to fa/ rats (P0.075) (Fig. 4b).
SDH enzyme activities did not differ between genotypes
and also remained unchanged with age (Fig. 4c). The
statistical analysis of complex IV activities illustrated a
significant effect of both genotype and age. Complex IV
activity was higher in 6-wk-old fa/fa rats compared to
control rats (Fig. 4d). Complex IV activity decreased in
both genotypes, but to a lesser extent in fa/fa rats,
resulting in higher enzyme activity in 19-wk-old fa/fa rats
compared to controls.
DISCUSSION
The present study aimed to clarify the order in which
changes in IMCL content and skeletal muscle mito-
TABLE 1. Concentrations of 31P metabolites and intracellular pH at rest
Measure
6 wk 12 wk 18 wk
fa/fa fa/ fa/fa fa/ fa/fa fa/
PCr (mM) 31.7  1.2 32.5  1.5 40.2  1.2b 38.5  1.0b 39.1  2.0b 39.5  1.6b
Pi (mM)a 3.2  0.7 2.5  0.6 3.1  0.7 2.3  0.5 4.3  0.6c 3.3  0.6c
Pi/PCra 0.1  0.02 0.08  0.02 0.08  0.02b 0.06  0.01b 0.11  0.02c 0.08  0.02c
ADP (M) 9.6  1.6 9.9  1.6 12.0  0.4b 11.4  0.5b 11.3  0.5 11.7  0.7
pH 7.04  0.08 7.05  0.07 7.14  0.02b 7.12  0.02b 7.11  0.02 7.13  0.03
a Significantly different between genotypes. b Significantly different compared to 6-wk-old animals. c Significantly different compared to
12-wk-old animals.
Figure 3. a) Stack plot of 31P MR spectra measured in TA during a time series of a 12-wk-old fa/ rat during a
rest-exercise-recovery protocol. Contractions were induced by electrical stimulation. The period of electrical stimulation (2 min)
is indicated with the arrows (start and stop). Time resolution20 s. Peaks are from Pi, PCr, and ATP. b) [PCr] during
rest-exercise-recovery protocol. Recovery data were fit with a monoexponential function (black line); 	PCr51.1 s. c) Average
	PCr of fa/fa (filled bars) and fa/ rats (open bars) at different ages. A higher value of 	PCr indicates a lower oxidative capacity.
$P0.05 vs. 6- and 18-wk-old rats. Error bars represent sd.
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chondrial function occur during the development of
type 2 diabetes in ZDF rats. We hypothesized that in
vivo mitochondrial oxidative capacity and in vitro activ-
ities of enzymes involved in oxidative metabolism would
show a progressive decrease parallel to the develop-
ment of type 2 diabetes. Furthermore, IMCL levels were
expected to increase during the development of type 2
diabetes. IMCL levels were higher in prediabetic fa/fa
rats than in controls and increased in fa/fa rats with the
development of type 2 diabetes. Although IMCL con-
tent did not continue to rise between 12 and 18 wk
of age, IMCL levels were always higher in fa/fa rats
compared to control animals. In agreement with our
hypothesis, in vivo mitochondrial oxidative capacity
progressively decreased throughout the duration of the
study, as evidenced by the increased time constant for
PCr recovery after exercise. However, since this oc-
curred to a similar degree in both ZDF genotypes, the
decreased oxidative capacity did not seem to play a
major role in the development of type 2 diabetes in the
fa/fa rats. In accordance with the in vivo measure-
ments, in vitro enzyme activities were not decreased in
fa/fa rats compared to control animals at any age.
VLCAD and complex IV activities were even higher,
and CS activity tended to be higher in late-stage dia-
betic fa/fa rats than in control fa/ rats.
The in vivo IMCL measurements confirm previous
results on muscle fiber type-related levels of IMCLs
within Wistar rat TA muscle (27), as in both ZDF
genotypes IMCL levels were 2–3 times higher in red TA
compared to white TA. Relative changes in IMCL levels
during the study were similar in white and red TA, both
in fa/fa and in fa/ rats. In general, the age-depen-
dent changes in IMCL content of ZDF rats are in good
agreement with earlier reports (8).
At 6 wk of age, in vivo skeletal muscle oxidative
capacity was identical in both genotypes despite the
hyperinsulinemic state of fa/fa rats. This implies that
hyperinsulinemia develops without skeletal muscle mi-
tochondrial dysfunction in the 6-wk-old fa/fa rats.
During the transition from the normoglycemic-hyper-
insulinemic state toward the hyperglycemic-hyperinsu-
linemic state, 	PCr in fa/fa rats gradually increased,
resulting in about 3 times higher values at 18 wk
compared to 6 wk of age. However, a similar change in
	PCr was observed in maturing normoglycemic-normo-
insulinemic fa/ rats. Therefore, this decrease in oxi-
dative capacity can most likely be entirely attributed to
TABLE 2. Concentrations of 31P metabolites and intracellular pH at the end of exercise
Measure
6 wk 12 wk 18 wk
fa/fa fa/ fa/fa fa/ fa/fa fa/
PCr (mM) 16.7  2.3 17.0  2.3 21.4  2.3b 19.9  2.0b 19.5  1.7b 21.8  1.6b
Pi (mM)a 21.1  3.7 17.7  1.8 20.5  3.7 15.8  2.4 22.5  4.4 17.6  2.9
ADP (M) 47.3  16.4 53.4  19.3 57.9  9.06b 67.2  9.8b 59.2  13.0 51.3  10.9
pH 6.86  0.11 6.91  0.07 6.98  0.08b 7.02  0.10b 6.93  0.02 6.96  0.06
a Significantly different between genotypes. b Significantly different compared to 6-wk-old animals.
Figure 4. Activities of VLCAD (a), CS (b), SDH
(c), and complex IV (d) in the different ZDF
genotypes at different ages. Activities were de-
termined in 6 animals/group. *P0.05 vs. fa/
rats of the same age; #P0.05 vs. 6-wk-old
animals of same genotype; $P0.05 vs. 12-wk-
old animals of same genotype. Error bars rep-
resent sd.
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aging of the animals. Healthy Wistar rats display a
similar degree of age-related decrease in oxidative
capacity, and 	PCr values of the TA are similar to those
measured in ZDF rats (data not shown). Thus, our data
do not reveal apparent mitochondrial dysfunction in
the diabetic ZDF phenotype. On the other hand, we
cannot completely exclude that the combination of
both the age-related decrease of in vivo mitochondrial
oxidative capacity and high IMCL levels contributed to
the development of type 2 diabetes.
Sanderson et al. (40) measured PCr recovery kinetics
in 15-wk-old, obese, insulin-resistant Zucker rats. There
were no differences observed in 	PCr between obese
Zucker rats and lean controls; CS activities were also the
same (40). In contrast, Klein et al. (41) reported slower
postexercise recovery of PCr in obese Zucker rats
compared to lean controls. However, their 31P MR
spectra were recorded with relatively low time resolu-
tion (2 min), which impeded a robust quantitative
analysis of the recovery data. Furthermore, the end-
exercise pH was significantly lower in the obese
animals, which does not allow comparison of the PCr
recovery rates between both animal groups, as was
also argued by the authors (41).
To study diet-induced alterations in skeletal muscle
mitochondrial function, Chanseaume et al. (42) fed
Wistar rats a high-fat diet and sacrificed them at sequen-
tial time points. Measuring in vitro mitochondrial res-
piration and ATP production in skinned muscle fibers,
they found no differences in the TA muscle of Wistar
rats fed a high-fat diet compared with control animals,
which is in agreement with our results. However, in a
later stage, after 40 days of consuming a high-fat diet,
the soleus muscle showed a decrease in oxidative
phosphorylation activity (42). In young Wistar rats fed
a high-fat diet for 15 days, increased lipid oxidative
capacity was measured in muscle homogenates and
subsarcolemmal and intermyofibrillar mitochondria
(43). More recently, however, the same group showed
that a longer period (7 wk) of high-fat diet consump-
tion in adult rats resulted in a lower respiratory capacity
of subsarcolemmal mitochondria (44). The duration of
the diet and the age of the animals at the start of the
intervention have been proposed as factors accountable
for these different results in Wistar rats (44, 45). In
diet-induced insulin-resistant mice, skeletal muscle mi-
tochondrial function was not affected after 4 wk of diet.
However, after 16 wk of high-fat and high-sucrose diet,
reactive oxygen species (ROS) induced mitochondrial
dysfunction (46). The data from these diet-induced
diabetic mice suggest that mitochondrial alterations do
not precede insulin resistance and result from in-
creased ROS production in muscle (46). Although we
have studied relatively long-term effects of insulin resis-
tance and type 2 diabetes, we cannot exclude that at
older age, a decreased in vivo oxidative capacity might
develop in fa/fa rats secondary to longer exposure to
overt type 2 diabetes.
Although PCr recovery analysis provides an excellent
measure of in vivo mitochondrial oxidative capacity in
general, it does not offer information about the pattern
of substrates utilized by the mitochondrial respiratory
chain. Keeping in mind the short duration of the
muscle contraction protocol, it is fair to assume that the
oxidative phosphorylation during contraction and re-
covery relies predominantly on carbohydrates as a fuel.
Differences in fat oxidative capacity that do not lead to
a general dysfunction of the mitochondria will there-
fore remain undetected in postexercise PCr recovery
analysis. However, in vitro VLCAD activity did not show
an impairment in fa/fa animals, either. Rather, the
opposite occurred, as we observed a significant up-
regulation of VCLAD activity in fa/fa rats compared to
control rats at 12 and 19 wk of age. Furthermore, at any
age, in vitro activities of CS, SDH, and complex IV were
similar or increased in fa/fa rats compared to fa/ rats,
pointing toward overall normal functioning of mito-
chondrial machinery. The in vitro data are in agree-
ment with Turner et al. (47), who studied various
rodent models of high-fat-diet-induced insulin resis-
tance and measured increased activity of medium-chain
acylCoA dehydrogenase (another enzyme of the -oxi-
dation, comparable to VLCAD) and increased activity
of CS in fa/fa rats. In addition, they reported increased
in vitro fatty acid oxidative capacity in muscle homoge-
nates and isolated mitochondria (47). Also, protein
expression of peroxisome proliferator-activated recep-
tor  coactivator (PGC) -1, a strong activator of
mitochondrial biogenesis and oxidative metabolism,
and several mitochondrial respiratory chain complexes
were found to be up-regulated. Both in vivo and in vitro
data of the present study are in line with these findings,
as high IMCL accumulation in fa/fa rats does not seem
to be induced by decreased muscle mitochondrial
oxidative capacity. In accordance, 8 wk of high-fat diet
consumption in Wistar rats resulted in increased IMCL
levels but did not affect intrinsic mitochondrial func-
tioning (45).
Genetic models of obesity and insulin resistance are,
in general, characterized by an early-established pheno-
type. The ZDF rat model allows studying the transition
from insulin resistance toward overt type 2 diabetes, but
not investigation of the mechanisms involved in the
development of insulin resistance itself, as the latter is
presumably already present in 6-wk-old animals (26).
Longitudinal in vivo studies of animal models of slowly
progressing skeletal muscle insulin resistance are ex-
pected to give crucial insights into the role of mito-
chondrial oxidative capacity in that pathological condi-
tion.
Studies in animal models of lipid-induced insulin
resistance do not exclude the possibility that an intrinsic
defect in the skeletal muscle fatty acid oxidative ma-
chinery might lead to accumulation of triglycerides and
fatty acid metabolites and thereby induce insulin resis-
tance. Dobbins et al. (7) showed that inhibiting carni-
tine palmitoyltransferase-1, thereby blocking the entry
of fatty acids into mitochondria, resulted in increased
IMCL content, decreased whole-body insulin sensitivity,
and decreased glucose disposal in skeletal muscle of
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rats. On the other hand, long-chain acyl-CoA dehydro-
genase (48) and PGC-1 knockout mice (49) did not
show any signs of decreased insulin sensitivity of skele-
tal muscle tissue. Remarkably, two mouse models char-
acterized by progressive loss of respiratory chain func-
tion and activity even showed improved glucose
homeostasis and skeletal muscle insulin sensitivity (50,
51). Even more surprisingly, reduced mitochondrial
activity made these mice resistant to diabetes and
obesity (51). Whether these transgenic mouse models
generated compensatory mechanisms protecting them
from developing insulin resistance remains to be eluci-
dated.
CONCLUSIONS
We used minimally invasive MRS methods to collect
unique longitudinal data of in vivo mitochondrial oxi-
dative capacity and IMCL levels in ZDF rats at different
stages throughout the development of type 2 diabetes.
Despite increased IMCL levels, in vivo mitochondrial
oxidative capacity did not differ between diabetic and
control animals, neither in the prediabetic state nor
during full-blown type 2 diabetes. The in vivo MRS
results were corroborated by in vitro enzyme activity
data, suggesting even an improved capacity of enzymes
involved in fat oxidation in the type 2 diabetic animals.
Accordingly, we can conclude that in the ZDF rat
model, the transition from insulin resistance to type 2
diabetes does occur in the absence of skeletal muscle
mitochondrial dysfunction.
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